Metyrapone for Mild Autonomous Cortisol Secretion (MACS)
Condition(s):Autonomous Cortisol Secretion; Mild Autonomous Cortisol Secretion (MACS)Last Updated:January 17, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Autonomous Cortisol Secretion; Mild Autonomous Cortisol Secretion (MACS)Last Updated:January 17, 2024Recruiting
Condition(s):Internal HemorrhoidLast Updated:March 13, 2024Recruiting
Condition(s):HealthyLast Updated:December 21, 2023Recruiting
Condition(s):Hematopoietic and Lymphoid System Neoplasm; Malignant Solid NeoplasmLast Updated:December 28, 2023Active, not recruiting
Condition(s):Blood DonationLast Updated:January 5, 2024Recruiting
Condition(s):Healthy; AgingLast Updated:February 29, 2024Recruiting
Condition(s):ARDS; COVID-19; Mechanical Ventilation Pressure High; Ventilator-Induced Lung InjuryLast Updated:March 7, 2024Withdrawn
Condition(s):Effects of GAHT, on Skeletal Muscle in TGDLast Updated:January 18, 2024Recruiting
Condition(s):Metastatic Breast CancerLast Updated:October 17, 2023Recruiting
Condition(s):Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Locally Advanced Lung Carcinoma; Locally Advanced Malignant Solid Neoplasm; Locally Advanced Melanoma; Metastatic Lung Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Stage III Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8Last Updated:October 10, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.